Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Geisinger

Neither a doctor nor a teaching hospital

Research payments

$548,498

60 payments

Through program year 2025, Geisinger is reported as receiving $548,498 in research payments, across 60 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $64,470 23
2024 Research $73,312 5
2023 Research $69,313 3
2022 Research $91,375 5
2021 Research $3,000 2
2020 Research $147,966 8
2019 Research $99,062 14

Breakdown

Who paid Research payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $413,798 24 payments
  2. HeartFlow, Inc. $64,470 23 payments
  3. AstraZeneca UK Limited $48,260 7 payments
  4. Alexion Pharmaceuticals, Inc. $15,120 2 payments
  5. AbbVie, Inc. $3,750 1 payment
  6. Ge Healthcare $3,000 2 payments
  7. Sanofi US Services Inc. $100 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia $234,826 18 payments
  2. Dapagliflozin in Acute Decompensated Heart Failure $187,300 6 payments
  3. 459 DECIDE Registry $64,470 23 payments
  4. Multicenter Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis $25,120 1 payment
  5. A Phase 4 Randomized Clinical Trial of Andexanet Alfa, Andexanet Alfa for Injection, in Acute Intracranial Hemorrhage in Patients Receiving An Oral Factor Xa Inhibitor $15,120 2 payments
  6. A Multinational Randomised Double Blind Placebo Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death Myocardial Infarction or Stroke in Patients with Type 2 Diabetes $8,452 3 payments
  7. Treatment Patterns Outcomes and Patient Reported Quality of Life A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents $6,360 3 payments
  8. M16-135 $3,750 1 payment
  9. Can Aeromedical Crews Accurately Interpret and Transmit Prehospital Efast Images With A Handheld Ultrasound MacHine? $3,000 2 payments
  10. Fabry Disease Registry Protocol $100 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record